Dow Up1.06% Nasdaq Up0.04%

Anika Therapeutics Inc. (ANIK)

-NasdaqGS
40.97 Up 0.18(0.44%) 2:59PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 26,275   34,010   21,251   17,754  
Cost of Revenue5,333  4,361  6,235  5,378  
Gross Profit 20,942   29,649   15,016   12,377  
Operating Expenses
Research Development1,873  2,288  2,030  1,618  
Selling General and Administrative3,866  3,491  2,400  3,189  
Non Recurring -   -  156  (196)
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 15,203   23,871   10,431   7,766  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes15,209  23,871  10,412  7,733  
Interest Expense -   -   -   -  
Income Before Tax15,209  23,871  10,412  7,733  
Income Tax Expense5,906  8,841  3,758  2,776  
Minority Interest -   -   -   -  
Net Income From Continuing Ops9,302  15,030  6,654  4,957  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 9,302   15,030   6,654   4,957  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 9,302   15,030   6,654   4,957  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.